PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study

NCT01266096 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Newly Diagnosed or Recurrent Metastatic Melanoma Patients
Malignant Brain Tumors

Interventions

DRUG: PET scan with 124I-cRGDY-PEG-dots

Sponsor

Memorial Sloan Kettering Cancer Center